
[Image from Unsplash]
That was the big takeaway from a four-expert panel at DeviceTalks Minnesota last month. (The next DeviceTalks is Oct. 2 in Boston.)
Charlie Whelan, director of transformational health consulting at Frost & Sullivan, led a discussion with Anne Sissel, managing director for Baxter Ventures; Kathleen Tune, an advisor at Thomas, McNerney & Partners; and Dr. Dennis Wahr, president and CEO of Nuvaira.
Here are five important insights that came out of the discussion.
Next>>
[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]